Maze Therapeutics, Inc. (MAZE) Misses Q2 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| (NASDAQ: MAZE) | Delayed: 30.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.37 | 52 Week High | $ | |||
| Open | $30.37 | 52 Week Low | $ | |||
| Day High | $30.37 | P/E | N/A | |||
| Day Low | $30.37 | EPS | $ | |||
| Volume | 1,055 | |||||
